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Epstein–Barr virus (EBV) is a human γ-herpesvirus that primarily infects B lymphocytes and epithelial cells. Entry of EBV into B cells
requires the viral glycoproteins gp42, gH/gL and gB, while gp42 is not necessary for infection of epithelial cells. In EBV, gH and gL form two
distinct complexes, a bipartite complex that contains only gH and gL, used for infection of epithelial cells, and a tripartite complex that
additionally includes gp42, used for infection of B cells. The gH/gL complex is conserved within the herpesvirus family, but its exact role in entry
and mechanism of fusion is not yet known. To understand more about the functionality of EBVgH/gL, we investigated the functional homology of
gHs and gLs from human herpesvirus 8 (HHV8) and two primate (rhesus and marmoset) γ-herpesviruses in EBV-mediated virus-free cell fusion
assay. Overall, gHs and gLs from the more homologous primate herpesviruses were better at complementing EBV gH and gL in fusion than
HHV8 gH and gL. Interestingly, marmoset gH was able to complement fusion with epithelial cells, but not B cells. Further investigation of this led
to the discovery that EBVgH is the binding partner of gp42 in the tripartite complex and the absence of fusion with B cells in the presence of
marmoset gH/gL is due to its inability to bind gp42.
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Epstein–Barr virus (EBV) is a γ-herpesvirus, from the
lymphocryptovirus (LCV) subgroup, that readily infects B
lymphocytes and epithelial cells (Kieff and Rickinson, 2001;
Spear and Longnecker, 2003). The initiation of infection by
EBV is driven by interaction of viral glycoproteins with cell
surface receptors. The glycoproteins required for EBV entry
differ between epithelial and B cells; gB, gH and gL are
essential for infection of both epithelial and B cells, while gp42
is required only for B cell entry (Haan et al., 2001; Li et al.,
1995; Wang et al., 1998). Viral glycoprotein gp42 binds to B
cell surface protein HLA class II, which triggers B cell fusion
mediated by gB, gH and gL (Li et al., 1997b; Speck et al.,
2000). No EBV receptor for epithelial cells has been identified
yet, but recent evidence suggests existence of an epithelial cell
receptor for gH and the interaction of gH with its receptor has⁎ Corresponding author.
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doi:10.1016/j.virol.2007.03.054been proposed to serve as a trigger for epithelial cell fusion
(Borza et al., 2004; Wu et al., 2005).
EBV glycoproteins gH and gL form a heteromeric complex
which has been recently discovered to occur in a 1:1 ratio
(Kirschner et al., 2006; Yaswen et al., 1993). The formation of a
gH/gL complex is conserved throughout the herpesvirus family
(Spear and Longnecker, 2003). gH is generally thought to be
directly involved in the fusion process, while gL is thought to be
important for proper processing and transport of gH to the cell
surface (Pulford et al., 1994, 1995; Yaswen et al., 1993). In
addition to the bipartite gH/gL complex, EBV gH and gL also
form a tripartite complex that includes gp42. These two
complexes have a mutually exclusive ability to mediate
infection of epithelial (gH/gL) and B cells (gH/gL/gp42), and
are both present on EB virions (Wang et al., 1998).
EBV-related γ-herpesviruses, from the Lymphocryptovirus
genus, have been reported to naturally infect both Old and New
World nonhuman primates (Ehlers et al., 2003; Wang, 2005).
EBV and the Old World LCV genomes are highly homologous
(e.g. homology between EBV and rhesus LCV is 75.6%)
158 J. Omerović, R. Longnecker / Virology 365 (2007) 157–165(Rivailler et al., 2002b), and the repertoire of lytic and latent
genes is virtually identical (Cho et al., 1999). The New World
LCVs are more distant from EBV and Old World LCVs (e.g.
homology between EBV and marmoset LCV is 47.3%) (Cho et
al., 2001) but they are unified by their common biological
properties (Wang et al., 2001). HHV8 is another γ-herpesvirus
that infects humans but it belongs to the genus Rhadinovirus
(Moore et al., 1996). The rhadinoviruses have also been
reported to infect nonhuman primates (Damania and Desrosiers,
2001).
gH and gL play a central role in EBVentry and entry of other
herpesviruses, but the exact role(s) of this complex in the fusion
process is poorly understood. Interestingly, despite this
functional conservation, a low sequence homology in gH and
gL across and within subfamilies has been detected. Even
though HHV8 and EBV are both members of γ-herpesvirus
family, the homology between proteins of these two viruses is in
general between 20% and 40% (Gupta et al., 2000; Lin et al.,
1997; Lukac et al., 1998; Pertel et al., 1998; Sun et al., 1998).
Thus, HHV8 gH and gL have 26.5% and 24.2% identity and
48.3% and 53.8% similarity to EBV gH and gL, respectively
(Russo et al., 1996). EBV gH and gL share a much higher
degree of homology with gH and gL from nonhuman LCVs. For
example, marmoset LCV gH and gL have 44.6% and 50.4%
sequence homology with EBV, respectively, while the degree of
conservation is even higher with rhesus LCV, 85.1% for gH and
81.6% for gL (Rivailler et al., 2002a, 2002b). In this report we
examined the ability of rhesus LCV (Rh), marmoset LCV (M)
and HHV8 gH and gL to substitute for EBV gH and gL in
fusion with epithelial and B cells. By performing this analysis,
we have shown that gH/gL complexes are sensitive to cross-
virus complementation.
Results
Rhesus gH is functional in EBV-mediated fusion with epithelial
and B cells
To investigate the functional homology between gH and gL
from EBV and other related γ-herpesviruses, gH and gL from
common marmoset LCV (M), rhesus monkey LCV (Rh) and
human herpesvirus 8 (HHV8) were tested for their ability to
substitute EBV gH and/or gL and mediate fusion with other
EBV glycoproteins. For this purpose, Rh and M glycoproteins
were cloned into a pCAGGS vector, previously used for
expression of EBVand HHV8 glycoproteins (Haan et al., 2001;
Pertel, 2002). gH and gL from rhesus LCV were examined first
since this virus is the most homologous to EBV. Rhesus LCV is
capable of infecting human B cells in vitro (Moghaddam et al.,
1998) but glycoproteins involved in entry of rhesus LCV have
never been characterized. Prior to testing the heterologous Rh/
EBV complexes in the fusion assay, we examined the cell
surface expression of these complexes. Since no antibodies
(Abs) against rhesus gH and gL were available we used two
antibodies previously generated against EBVgH/gL complex,
the E1D1 and the HL800 antibodies. The E1D1 recognizes the
native gH/gL complex and blocks epithelial cell entry andfusion, while it has no effect on entry of EBV into B cells and B
cell fusion (Li et al., 1995; McShane and Longnecker, 2004).
The HL800 recognizes both EBV gH and gL (Omerovic et al.,
2005). Since there is a high degree of homology between EBV
and Rh gH and gL, it was not surprising that both antibodies
cross-reacted with rhesus glycoproteins and all of the
complexes were detected at the cell surface (Fig. 1A).
Interestingly, EBVgH/RhgL exhibited a greatly reduced bind-
ing to the E1D1 Ab. Since RhgH/gL bound this Ab as well as
did EBVgH/gL this suggests that reduced binding was not due
to the absence of residues recognized by the E1D1 antibody but
rather a conformational change in the epitope due to a defect in
gH/gL complex formation.
We next examined the functionality of these complexes by
testing their ability to mediate fusion with other EBV
glycoproteins. For this purpose a cell–cell in vitro fusion
assay was used (Haan et al., 2001). All of the heterologous gH/
gL complexes were functional in epithelial cell fusion (Fig. 1B).
Interestingly, RhgH when paired with EBVgL mediated fusion
with epithelial cells at greatly higher levels, as well as did
RhgH/gL complex when compared to the EBVgH/gL. The
complex of EBVgH and RhgL was still able to function in
fusion with epithelial cells, but at somewhat lower levels. Since
the conformation of this complex was altered according to the
data with the E1D1 Ab and the epitope that E1D1 recognizes is
important for epithelial cell fusion (Li et al., 1995; McShane and
Longnecker, 2004), a decrease in fusion with epithelial cells
was not surprising. However to our surprise the B cell fusion of
EBVgH/RhgL complex was at only 20% of wild-type levels. In
fact, the two complexes that contained RhgL (EBVgH/RhgL;
RhgH/gL) had a very low, almost undetectable, fusion levels
with B cells.
Since gp42 is required for EBV-mediated fusion with B cells
and low levels of fusion with B cells could be due to a defect in
gp42 association with gH/gL complex, we next examined
whether these complexes were able to bind to gp42. In order to
visualize gH and gL on the Western blot, the cell surface
proteins of transfected cells were labeled with biotin and lysates
immunoprecipitated for gp42. As shown in Fig. 1C, all of the
gH/gL complexes immunoprecipitated with gp42. This sug-
gested that the low levels of fusion seen when RhgL was paired
with either Rh or EBV gH are not due to the inability of these
complexes to bind to gp42 but rather some other defect such as
an alteration in the overall structure of the complex or a failure
of gp42 to trigger fusion. Interestingly, we constantly observed
higher expression of RhgH in the Western blots, that was not
dependent on the DNA preparation used, suggesting that the
enhancement in fusion observed could be partially due to a
higher cell surface expression.
Marmoset gH complements fusion with epithelial but not B
cells
Similar to rhesus glycoproteins, the cell surface expression
of heterologous complexes of marmoset (M) and EBV gH and
gL was examined by CELISA (Fig. 2A). Only the complex of
MgH and EBVgL was cross-reactive with the E1D1 Ab,
Fig. 2. Marmoset gH complements fusion with epithelial but not B cells. CHO-K1
cells transfected with EBVgp42, EBVgB and different combinations of marmoset
and EBV gH and gL were used in CELISA (A) and in the fusion assay (B). The
combinations of gH/gL tested are shown on the X-axes (M=marmoset). (A) The
cell surface expression of gH/gL measured by CELISA was performed using an
anti-EBVgH/gL Ab, E1D1 (black bars), and an anti-HA Ab, HA.11 (dotted bars).
Both MgL and EBVgL were tagged with an HA tag at the C terminus. (B) As
described in Fig. 1, CHO-K1 cells were overlaid with either Daudi B cells (dark
bars) or kidney epithelial 293 cells (light bars) and luciferase activity measured
24 h later. Luciferase activity was normalized to wild-type levels, which was set to
100% for both cell types. The fusion activity of HA-tagged complexes was
comparable to the levels observed with the untagged constructs (data not shown).
Data in panel B are averages of three independent experiments and a representative
experiment measured in triplicate is shown in panel A.
Fig. 1. Rhesus gH is functional in EBV-mediated fusion with epithelial and B
cells. CHO-K1 cells were transiently transfected with EBV glycoproteins gp42
and gB and different combinations of gH and gL, as shown (Rh=rhesus). (A)
Postransfection, cells were transferred to 96 wells and assayed for gH/gL cell
surface expression by CELISAwith two different EBVgH/gL antibodies, E1D1
(black bars), a mouse monoclonal Ab, and HL800 (hatched bars), a rabbit
polyclonal Ab. A representative experiment measured in triplicate is shown. (B)
Transfected CHO-K1 cells were overlaid with either Daudi B cells (black bars)
or 293T kidney epithelial cells (gray bars) at 1:1 ratio and relative luciferase
activity measured 24 h later. Luciferase activity was normalized to wild-type
levels, which was set to 100% for both cell types. Data are averages of three
independent experiments with the standard deviations indicated by vertical lines.
(C) CHO-K1 cells were harvested 36 h post transfection and the cell surface
proteins labeled with biotin at 4 °C. Biotinylated lysates were immunopreci-
pitated with the F-2-1 Ab (an anti-gp42 mouse monoclonal Ab) and probed with
avidin–HRP in a Western blot. Proteins of interest are indicated with arrows.
Positions of prestained protein markers (in kDa) are indicated.
159J. Omerović, R. Longnecker / Virology 365 (2007) 157–165showing it was expressed at the cell surface. The ability of
MgH/EBVgL to bind the E1D1 Ab also suggested that this
complex is in a similar conformation as the EBVgH/gL
complex. In order to examine the cell surface expression of
the rest of the complexes, that were not cross-reactive with theE1D1 Ab, we utilized HA-tagged constructs of EBVand M gL.
The tagged constructs were used to more quantitatively measure
the cell surface expression of given complexes. Marmoset and
EBV gL were not expressed at the cell surface in the absence of
gH, as measured by CELISA (data not shown). Thus, the levels
of expression detected with an anti-HA Ab were directly related
to the amount of gH/gL complexes present at the cell surface.
As shown in Fig. 2A, the expression of MgH/gL and MgH/
EBVgL complexes when analyzed with an anti-HA Ab was
comparable to the EBVgH/gL cell surface expression. How-
ever, when MgL was substituted for EBVgL, only a low amount
of gH/gL was detected at the cell surface. These results were
similar to the data on EBVgH/RhgL suggesting that EBVgH/gL
complex is sensitive to cross-species substitution in gL.
Furthermore, we examined the heterologous complexes of
EBV and marmoset gH and gL functionally in the fusion assay
(Fig. 2B). As expected, the complex of EBVgH and MgL that
was poorly expressed at the cell surface did not mediate fusion
with either B cells or epithelial cells. Interestingly, when MgH
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served with epithelial but not B cells. This raised a possibility
that the MgH/EBVgL and MgH/gL complexes were unable to
associate with gp42 and thus unable to mediate fusion with B
cells. It is important to note that HA-tagged MgL and EBVgL
constructs were confirmed to mediate fusion at levels compar-
able to untagged proteins (data not shown).
EBVgH is the binding partner of EBVgp42 and marmoset
gH/gL is unable to bind to EBVgp42
To explore the possibility that complexes containing MgH
were unable to mediate fusion with B cells due to a failure to
interact with gp42, we examined the association of gp42 and
different combinations of gH/gL at the cell surface by co-
immunoprecipitation. As shown in Fig. 3A, immunoprecipitation
of gL with an anti-HA Ab co-immunoprecipitated gH. The levels
of cell surface gH that co-immunoprecipitated correlated with
the levels of given complexes expressed at the cells surface (Fig.
2A). Interestingly, neither the MgH/EBVgL nor MgH/gL
complex was able to bind to gp42 while the positive control of
EBVgH/gL clearly co-immunoprecipitated gp42 (Fig. 3B). gp42
co-immunoprecipitated poorly with the EBVgH/MgL complex.
In a reverse experiment, the MgH/EBVgL andMgH/gL complexesFig. 3. EBVgH is the binding partner of EBVgp42 and marmoset gH/gL is
unable to bind to EBVgp42. CHO-K1 were transiently transfected with EBV
gp42, gB and different combinations of marmoset and EBV gH and gL, and cell
biotinylated at 4 °C (M=marmoset). Cells were lysed, immunoprecipitated with
either an anti-HA Ab (HA.11) (A and B) or an anti-gp42 Ab (F-2-1) (C and D)
and SDS-PAGE performed. Avidin–HRP was used to detect biotinylated
proteins (A, C and D) and an anti-gp42 rabbit polyclonal Ab (PB1114) (B) to
detect gp42 associating with gH/gL. Both EBVgL and MgL were labeled with
an HA tag at their C-termini. EBVgL was omitted from transfection in lane 3 in
both C and D. The proteins of interest are indicated with arrows. Positions of
prestained protein markers (in kDa) are indicated.also did not co-immunoprecipitate with EBVgp42 (data not
shown). Therefore, these data indicate the inability of MgH/
EBVgL andMgH/gL complexes to mediate fusion with B cells is
due to their failure to bind gp42.
It is not clear yet how gp42 binds to gH/gL: whether it binds
to both gH and gL or whether only one member of this complex
is the binding partner of gp42. Since EBVgH/MgL was still able
to bind gp42, it is suggestive that EBVgH is the binding partner
of gp42. Thus, to further investigate the interaction between
EBVgH/gL and gp42, we omitted either gH or gL from our
transfections and immunoprecipitated for gp42. Fig. 3C shows
that immunoprecipitation of gp42 resulted in co-immunopreci-
pitation of EBVgH in the absence of EBVgL. No EBVgL was
co-immunoprecipitated with gp42 when expressed without
EBVgH (data not shown). In contrast, neither MgH (Fig. 3D)
nor MgL (data not shown) was immunoprecipitated with gp42.
These data indicate that EBVgH is the binding partner of gp42
and suggest that the inability of MgH to bind EBVgp42 is due to
absence of gp42 binding domain(s).
Heterologous complexes of EBV/HHV8 are not expressed at
the cell surface and thus are nonfunctional in fusion
To further investigate difference in fusion function for gH
and gL, we next studied gH and gL from HHV8 in EBV-
mediated fusion. HHV8 gH and gL, along with HHV8gB, were
shown previously to be required for HHV8-mediated fusion
with B cells and epithelial cells (Pertel, 2002). Even though,
EBV and HHV8 belong to the same subfamily of human
herpesviruses, compared to the nonhuman primate LCVs, the
sequence homology of EBVand HHV8 gH and gL is fairly low.
The cell surface expression of heterologous EBV/HHV8
complexes was first examined using the EBV-specific gH/gL
Abs, but no cross-reactivity was observed with HHV8 gH and
gL (data not shown). Also, the Ab that was previously used for
HHV8 gH/gL did not give a sufficient signal in our system (data
not shown) (Pertel, 2002). Thus, similar to above, in order to
examine the cell surface expression we utilized HA-tagged EBV
and HHV8 gL. As shown in Fig. 4A, the cell surface expression
of HHV8gH/EBVgL complex was at background levels
(vector), while the expression of EBVgH/gL and HHV8gH/gL
complexes was at 7 and 4.5 fold above background, respectively.
Since HHV8gL is expressed at the cell surface in the absence of
gH (data not shown), the expression of EBVgH/HHV8gL
complex was assessed by using a Flag-tagged EBVgH. The
signal detected with an anti-Flag Ab was a measure of EBVgH/
HHV8gL expression at the cell surface which was undetectable
(Fig. 4B).
In our final series of experiments, HHV8 gH and gL were
tested in fusion with EBV glycoproteins. Since none of the
heterologous EBV/HHV8 complexes were expressed at the cell
surface, it was not surprising that those complexes did not
mediate fusion with either B cells or epithelial cells (Fig. 4C)
and the complexes were also not able to associate with gp42 at
the cell surface (Fig. 4D). The fusion levels of tagged constructs
were comparable to the untagged proteins (data not shown).
EBVgH-Flag was detected at the same size by Western blot as
Fig. 4. Heterologous complexes of EBV/HHV8 are not expressed at the cell surface and thus are nonfunctional in fusion. As described above, CHO-K1 cells were
transfected with EBV gp42, gB and different combinations of gH and gL, as indicated on the X-axes. (A and B) The cell surface expression of different gH and gL
complexes was assessed by CELISA as described before. Either an anti-HA (HA.11) (A) or anti-Flag (M2) antibody (B) was used. EBVgH construct with the Flag-tag
was used to assess the cell surface expression of EBVgH/HHV8 gL complex since HHV8gL is expressed by itself at the cell surface (data not shown). No gp42 was
included in transfection in panel B, since some EBVgH is expressed at the cell surface in the absence of EBVgL if gp42 is present (data not shown). Representative
experiments performed in triplicate are shown. (C) Posttransfection, CHO-K1 cells were overlaid with target cells and fusion assessed 24 h later. Luciferase activity
was normalized to wild-type levels, which was set to 100% for both cell types. Data are average of three independent experiments. (D) Biotinylated lysates of
transfected CHO-K1 cells were immunoprecipitated with an anti-HA Ab and Western probed with avidin–HRP. No association between HHV8 gH and/or gL with
EBVgp42 was observed at the cell surface. The proteins of interest are indicated with arrows. Positions of prestained protein markers (in kDa) are indicated.
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HHV8gH/gL was unable to bind gp42 and thus unable to
mediate fusion with B cells, when this complex was paired with
EBVgB fusion with epithelial cells was observed. This indicated
that the HHV8 gH and gL we used were functional. The HHV8
constructs we used in our study were the same ones previously
used to described HHV8 cell–cell fusion (Pertel, 2002).
Discussion
The main focus of this paper was to examine the functional
conservation of gH and gL from human and nonhuman primate
γ-herpesviruses in EBV-induced membrane fusion. Overall,
gHs and gLs from more closely related primate herpesviruseswere better at complementing EBV gH and gL in EBV-induced
membrane fusion than HHV8 gH and gL and the most sensitive
to cross-virus complementation were complexes in which
EBVgL was substituted (Table 1). Interestingly, the results on
heterologous complexes of EBV/HHV8 gH/gL contrast with
earlier studies from Dr. Hutt-Fletcher examining the chaperone
function of VZVgL in place of EBVgL (Li et al., 1997a). In
Dr. Hutt-Fletcher's study, it was shown that complexes of
VZVgL and EBVgH are expressed at the cell surface of trans-
fected cells (Li et al., 1997a). The heterologous complexes were
not investigated for function in fusion, but it is interesting that
gL from a more distantly related herpesvirus can function for
the EBVgL chaperone function when the more closely related
HHV8gL can not. One other difference of interest from earlier
Table 1
Summary of complementation results a
Glycoproteins Cell surface
expression
Binding
to gp42
B cell
fusion
Epithelial
cell fusion
Rh gH EBV gL + + + b + b
EBV gH Rh gL + + +/− c +
Rh gH Rh gL + + +/− c +
M gH EBV gL + − − +
EBV gH M gL +/− d +/− − −
M gH M gL + − − +
HHV8 gH EBV gL − − − −
EBV gH HHV8 gL − − − −
HHV8 gH HHV8 gL + − − +
a Summary of complementation results on EBV-mediated fusion with rhesus
(Rh), marmoset (M) and HHV8 gH and gL (columns 3 and 4). Cell surface
expression of these proteins when paired with either EBV gH or gL as well as
the expression of virus specific gH/gL is shown in column 1. Both heterologous
and homologous gH/gL complexes were also examined for their ability to bind
to EBVgp42 (column 2).
b Enhanced fusion, especially with epithelial cells.
c Very low fusion, not higher than 30%, but still detectable over the
background.
d Expression lower or undetectable with the E1D1 Ab.
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which contrasts with earlier studies in which gL was detected at
the cell surface (Li et al., 1995). This dissimilarity may be due to
differences in cell lines used (CV-1 in the previous studies
whereas we used CHO-K1 cells). In addition, a T7 expression
system using vaccinia virus was used in the previous studies
resulting in very high levels of expression of VZVgL. Whether
the cell type used, level of expression, or if even vaccinia
encoded proteins may influence gL expression on the cell
surface will require further investigation. Interestingly, previous
reports have indicated variation in whether or not gL is
expressed at the cell surface in herpesvirus family members.
VZVgL is also not expressed at the cell surface without gH; it is
retained inside the cell (Duus and Grose, 1996). On the other
hand, HHV8gL is detected at the cell surface even in the
absence of gH (data not shown). Additionally, HSV-1gL is not
expressed at the cell surface without gH, but unlike VZVgL,
HSV-1gL is secreted into the culture medium (Dubin and Jiang,
1995). Therefore, even though the formation of gH/gL complex
and its involvement in fusion is conserved across the
herpesvirus family, virus specific differences exist in processing
of gL and gH and the formation of the gH/gL complex.
A very important finding from this study is identifying
EBVgH as the sole binding partner of EBVgp42, similar to
studies published while this work was under review (Wu and
Hutt-Fletcher, 2007). To our surprise, EBVgH was also
expressed at the cell surface in the absence of gL if gp42 was
present, although at lower levels. Since MgH did not co-
immunoprecipitate with gp42 and did not function in fusion
with B cells, this finding suggested that MgH lacks domain(s)
required for interaction with gp42 and that these domains are
thus different from domains required for epithelial cell entry.
Further work will need to be conducted in order to identify the
exact domain(s) of EBVgH required for appropriate association
with gp42.Another particularly interesting result from the current study
suggests that gL may be important for fusion. A dramatic
reduction in B cell fusion was observed with RhgH/gL with
fusion levels at only about 5% over background. Since RhgH/
gL complex was expressed well at the cell surface, bound the
E1D1 antibody, associated with gp42 and RhgH mediated
fusion well when paired with EBVgL, these data in summary
suggest that gL is somehow involved in fusion and substitution
of EBVgL with RhgL was responsible for the reduction in
fusion observed. It is important to note that rhesus LCV has
been shown to infect human B cells in vitro (Moghaddam et al.,
1998), thus low levels of fusion observed with RhgH/gL in our
study could not be due an absence of a possible gH/gL receptor
on B cells. EBVgL, as well as gLs of other herpesviruses, are
thought to function as chaperones, essential for gH processing
and transport to the cell surface. However, our data suggests that
gL could also have a more direct role in fusion of at least B cells.
This may also explain the fusion results obtained with EBVgH/
RhgL complex. Even though this complex had lower cell
surface expression in the Western blot, which could have
resulted in a lower fusion, there was only a slight effect on
epithelial cell fusion in contrast to the significant reduction in B
cell fusion observed. Thus, it is possible that besides a defect in
processing of EBVgH, RhgL is also defective in participating in
fusion with B cells that is normally performed by EBVgL. A
highly unlikely possibility is that RhgL interferes with EBVgH
function and makes the complex nonfunctional, since RhgH/
RhgL complex is also a very poor mediator of B cell fusion (Fig.
1B). Another possibility is that gH/gL complex functions
differently than gp42/gH/gL complex in fusion, explaining the
difference we observed with RhgL between epithelial and B cell
fusion.
The work in this study was originally conducted to identify
functional domains of EBVgH/gL based on sequence homology
and complementation data. In this regard, the studies have been
very successful. By comparing EBV and Rh gL protein
sequences, excluding the signal sequences, there are differences
at only 16 amino acids. Of these, 7 are conservative
substitutions. Since the complex of EBVgH/RhgL has a reduced
ability to bind to the E1D1 Ab, mutating these 9 amino acids
could allow identification of residues important for a proper
EBVgH/gL complex formation. Further studies will now focus
on mutating individual amino acids within gL and the
construction of chimeric gH proteins with the results of these
studies providing an important basis to allow for the design and
construction of the various chimeras.
The present study provides a detailed comparison of function-
ality of gH/gL complexes fromdifferentγ-herpesviruses inEBV-
mediated fusion. Important clues have been obtained that will aid
further understanding of the role and domain(s) necessary for
proper function of EBVgH/gL in the fusion process. However, in
order to completely understand the function of gH/gL complex in
EBVentry, as well as other herpesviruses, it will be important to
resolve the gH/gL X-ray crystal structure. Since gH/gL is
essential for fusion, identification of functional domains will aid
in the development of therapeutics to treat EBV infection and
EBV-associated diseases.
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Cells and antibodies
All cells were grown in medium containing 10% FetalPlex
animal serum complex (Gemini Bio-Products) and 1% peni-
cillin–streptomycin (BioWhittaker). Chinese hamster ovary
cells (CHO-K1) kindly provided by Nanette Susmarski were
grown in Ham's F-12 medium (BioWhittaker). EBV-positive
HLA class II- and CD21-expressing Daudi B lymphocytes were
obtained from ATCC (Manassas, VA) and were grown in RPMI
1640 medium (BioWhittaker). To more easily monitor mem-
brane fusion, the Daudi 29 cell line stably expressing T7 RNA
polymerase was used (Silva et al., 2004). Human embryonic
kidney 293T cells were passaged in DMEM medium (BioWhit-
taker). 293T cells stably expressing T7 RNA polymerase were
utilized (Omerovic et al., 2005). Cells were grown in 75-cm2 cell
culture flasks (Corning), and adherent cells were detached by
using either trypsin-Versene (BioWhittaker) or Versene (phos-
phate-buffer saline [PBS]–1 mM EDTA).
Monoclonal antibodies E1D1 and F-2-1 were gifts from L.
Hutt-Fletcher (Louisiana State University Health Sciences
Center, Shreveport) and recognize the EBVgH/gL complex
and gp42, respectively (Balachandran et al., 1987; Strnad et al.,
1982). A large-scale preparation of the E1D1 and the F-2-1
antibodies was made at the Northwestern University Mono-
clonal Antibody Facility. The HL800 Ab is a polyclonal
antibody that recognizes EBV gH and gL as previously
characterized (Omerovic et al., 2005). HA.11 and Flag-M2
antibodies were purchased from Covance Research and Sigma,
respectively. Anti-rabbit HRP-conjugated antibody was pur-
chased from Cell Signaling.
Plasmid constructs
All of the genes of interest were expressed in pCAGGS
vector. Generation of plasmids expressing EBV glycoproteins
have been discussed elsewhere (Haan et al., 2001). Rhesus and
marmoset LCV gH and gL were PCR subcloned from cosmids
(rhesus: LV28, Cos9; marmoset: D6, A10) obtained from Dr.
FredWang into pCAGGS vector. QuickChangeMutagenesis Kit
was used to HA-tag both EBVand marmoset LCV gL at the C-
terminus. Primers containing the HA-tag sequence flanked by
either EBVor marmoset gL sequence at the 3′ end were used for
this purpose. A similar method was employed in constructing
Flag-tagged EBVgH, except the tag in this case was placed at the
N-terminus after residue 23, following the signal sequence (Wu
et al., 2005). HHV8 gH and gL, wild-type and HA-tagged, were
obtained from a former colleague Dr. Peter Pertel. As for EBV
and marmoset LCV gLs, HA-tag was placed at the C-terminus
on HHV8gL.
Transfection
All of the transfections were performed by a standard
protocol using Lipofectamine 2000 transfection reagent (Invi-
trogen). Twenty-four hours before transfection, CHO-K1 cellswere seeded in 6-well plates and the next day were transiently
transfected with 0.5 μg each of EBVgB and different combina-
tions of gL and gH (EBV, marmoset, rhesus or HHV8), 2 μg of
EBVgp42, and 0.8 μg of a luciferase-containing reporter plasmid
with a T7 promoter (Haan et al., 2001; Okuma et al., 1999). In
samples where gp42 was omitted, 2 μg of an empty pCAGGS
vector was included to maintain the total amount of DNA
constant. pCAGGS DNA was also used to compensate for
missing gH or gL as well. For Western blot experiments, CHO-
K1 cells were plated in T-25 cm2 cell culture flasks and 1 day
later transfected with EBV gp42, gB and different combinations
of gH and gL. In experiments examining the association between
gH/gL and gp42, either gH or gL were omitted from transfection
and an empty pCAGGS vector included instead to maintain the
amount of DNA constant.
Fusion assay
Effector CHO-K1 cells were transfected with plasmids
encoding the glycoproteins and a luciferase reporter plasmid as
stated above. Although the presence of gp42 can be inhibitory
in epithelial cell fusion, fusion still occurs (Li et al., 1995;
McShane and Longnecker, 2004). After 12 h, CHO-K1 and 293
cells were washed with PBS and detached with Versene. All
cells were counted with a Beckman Coulter Z1 particle counter,
then the effector and the target cells were mixed in equal
amounts (0.2×106 per sample) and plated into a 24-well plate in
Ham's F-12 medium (Haan et al., 2001; McShane and
Longnecker, 2004). Twenty-four hours later, the cells were
washed with PBS and lysed, and luciferase was quantified by
using the Promega Reporter Assay system. Relative luciferase
activity was measured on a Perkin-Elmer Victor plate reader.
Luciferase activity was normalized to wild-type levels, which
was set to 100% for both B cells and epithelial cells.
Cell enzyme-linked immunosorbent assay (CELISA)
CHO-K1 cells used for the fusion assay as described above
were also used to detect surface expression of the glycoproteins
via CELISA as described before (McShane and Longnecker,
2004). Briefly, transfected CHO-K1 cells were transferred into
96-well plates and 24 h later were incubated with different
primary antibodies, depending on the experiment. The follow-
ing primary antibodies were used: the mouse monoclonal E1D1
Ab, the rabbit polyclonal HL800 Ab, the mouse monoclonal
HA.11 Ab and the mouse monoclonal Flag-M2 Ab. The cells
were fixed and then incubated sequentially with the secondary
biotin conjugated anti-mouse IgG or anti-rabbit IgG (Sigma)
and tertiary antibodies. The plates were read as previously
described (McShane and Longnecker, 2004).
Immunoprecipitation of biotinylated cells and Western blotting
CHO-K1 cells were transfected as stated above. After 12 h,
the cells were washed with PBS and fresh Ham's F-12 medium
added. The cells were harvested 24 h later and washed three
times with ice-cold PBS. Following washes, cells were
164 J. Omerović, R. Longnecker / Virology 365 (2007) 157–165incubated with EZ-Link Sulfo-NHS-LC-Biotin (Pierce) by
rotating for 20 min at 4 °C. Biotin was inactivated by washing
three times with ice-cold 100 mM glycine–PBS. Cytoplasmic
lysates were prepared by lysing the cells with 1% Triton-X-100
lysis buffer (Silva et al., 2004) and the insoluble material was
removed by centrifugation at 4 °C. Cleared lysates were
immunoprecipitated overnight at 4 °C with either the E1D1,
HL800, F-2-1 or HA.11 Ab, depending on the experiment, and
captured with protein G-Sepharose (Amersham). Samples were
then washed three times in the lysis buffer, re-suspended in
sodium dodecyl sulfate (SDS) sample buffer, heated at 95 °C for
10 min, and pelleted by centrifugation. The supernatants were
separated on Bio-Rad 12.5% or 10% Criterion SDS-PAGE gels,
transferred to Immobilon-P membranes and blocked in Tris-
buffered saline with Tween-20 (TBST) with 5% milk for 1 h at
room temperature (RT), or overnight at 4 °C. The membranes
were probed for 30 min at RT with a horseradish peroxidase
(HRP)-conjugated-avidin (Bio-Rad) diluted at 1:2000 in
blocking solution. For studies examining the association of
gH/gL complex with gp42, membranes were incubated for 1 h
at RT with a rabbit polyclonal anti-gp42 antibody (PB1114)
diluted at 1:2000 in blocking solution. Membranes were washed
in TBSTand an anti-rabbit HRP-conjugated secondary antibody
(Cell Signaling) applied for 30 min at RT. Following five
washes, blots were mixed in equal volumes of ECL solutions
and exposed to hyperfilm (Amersham Biosciences).
Acknowledgments
We thank Dr. Lindsey Hutt-Fletcher for providing the E1D1
and the F-2-1 antibodies, Nanette Susmarski for cell line
expertise, and the members of the Longnecker Laboratory for
help and support. We also thank Dr. Fred Wang for supplying us
with cosmids containing primate gH and gL sequences and Lori
Lev for cloning these into a mammalian expression vector.
Finally, we thank Dr. Peter Pertel for untagged and HA-tagged
HHV8 gH and gL constructs.
R.L. is supported by Public Health Service grants CA62234,
CA73507, CA93444 and CA117794 from the National Cancer
Institute and AID067048. This work is supported in part by a
predoctoral fellowship from the American Heart Association,
Midwest Affiliate (J.O.).
References
Balachandran, N., Oba, D.E., Hutt-Fletcher, L.M., 1987. Antigenic cross-
reactions among herpes simplex virus types 1 and 2, Epstein–Barr virus, and
cytomegalovirus. J. Virol. 61 (4), 1125–1135.
Borza, C.M., Morgan, A.J., Turk, S.M., Hutt-Fletcher, L.M., 2004. Use of gHgL
for attachment of Epstein–Barr virus to epithelial cells compromises
infection. J. Virol. 78 (10), 5007–5014.
Cho, Y.G., Gordadze, A.V., Ling, P.D., Wang, F., 1999. Evolution of two types
of rhesus lymphocryptovirus similar to type 1 and type 2 Epstein–Barr virus.
J. Virol. 73 (11), 9206–9212.
Cho, Y., Ramer, J., Rivailler, P., Quink, C., Garber, R.L., Beier, D.R., Wang, F.,
2001. An Epstein–Barr-related herpesvirus from marmoset lymphomas.
Proc. Natl. Acad. Sci. U. S. A. 98 (3), 1224–1229.
Damania, B., Desrosiers, R.C., 2001. Simian homologues of human herpesvirus
8. Philos. Trans. R. Soc. Lond., B Biol. Sci. 356 (1408), 535–543.Dubin, G., Jiang, H., 1995. Expression of herpes simplex virus type 1
glycoprotein L (gL) in transfected mammalian cells: evidence that gL is not
independently anchored to cell membranes. J. Virol. 69 (7), 4564–4568.
Duus, K.M., Grose, C., 1996. Multiple regulatory effects of Varicella–Zoster
virus (VZV) gL on trafficking patterns and fusogenic properties of VZV gH.
J. Virol. 70 (12), 8961–8971.
Ehlers, B., Ochs, A., Leendertz, F., Goltz, M., Boesch, C., Matz-Rensing, K.,
2003. Novel simian homologues of Epstein–Barr virus. J. Virol. 77 (19),
10695–10699.
Gupta, A.K., Ruvolo, V., Patterson, C., Swaminathan, S., 2000. The human
herpesvirus 8 homolog of Epstein–Barr virus SM protein (KS-SM) is a
posttranscriptional activator of gene expression. J. Virol. 74 (2),
1038–1044.
Haan, K.M., Lee, S.K., Longnecker, R., 2001. Different functional domains in
the cytoplasmic tail of glycoprotein B are involved in Epstein–Barr virus-
induced membrane fusion. Virology 290 (1), 106–114.
Kieff, E., Rickinson, A.B., 2001. Esptein–Barr virus, In: Knipe, D.M., Howley,
P.M. (Eds.), 4th ed. vol. 2, Fields Virology. Lippincott Williams and
Wilkins, Philadelphia, PA, pp. 2575–2627.
Kirschner, A.N., Omerovic, J., Popov, B., Longnecker, R., Jardetzky, T.S., 2006.
Soluble Epstein–Barr virus glycoproteins gH, gL, and gp42 form a 1:1:1
stable complex that acts like soluble gp42 in B-cell fusion but not in
epithelial cell fusion. J. Virol. 80 (19), 9444–9454.
Li, Q., Turk, S.M., Hutt-Fletcher, L.M., 1995. The Epstein–Barr virus (EBV)
BZLF2 gene product associates with the gH and gL homologs of EBV and
carries an epitope critical to infection of B cells but not of epithelial cells.
J. Virol. 69 (7), 3987–3994.
Li, Q., Buranathai, C., Grose, C., Hutt-Fletcher, L.M., 1997a. Chaperone
functions common to nonhomologous Epstein–Barr virus gL and Varicella–
Zoster virus gL proteins. J. Virol. 71 (2), 1667–1670.
Li, Q., Spriggs, M.K., Kovats, S., Turk, S.M., Comeau, M.R., Nepom, B.,
Hutt-Fletcher, L.M., 1997b. Epstein–Barr virus uses HLA class II as a
cofactor for infection of B lymphocytes. J. Virol. 71 (6), 4657–4662.
Lin, S.F., Sun, R., Heston, L., Gradoville, L., Shedd, D., Haglund, K., Rigsby,
M., Miller, G., 1997. Identification, expression, and immunogenicity of
Kaposi's sarcoma-associated herpesvirus-encoded small viral capsid anti-
gen. J. Virol. 71 (4), 3069–3076.
Lukac, D.M., Renne, R., Kirshner, J.R., Ganem, D., 1998. Reactivation of
Kaposi's sarcoma-associated herpesvirus infection from latency by expres-
sion of the ORF 50 transactivator, a homolog of the EBVR protein. Virology
252 (2), 304–312.
McShane, M.P., Longnecker, R., 2004. Cell-surface expression of a mutated
Epstein–Barr virus glycoprotein B allows fusion independent of other viral
proteins. Proc. Natl. Acad. Sci. U.S.A. 101 (50), 17474–17479.
Moghaddam, A., Koch, J., Annis, B., Wang, F., 1998. Infection of human B
lymphocytes with lymphocryptoviruses related to Epstein–Barr virus.
J. Virol. 72 (4), 3205–3212.
Moore, P.S., Gao, S.J., Dominguez, G., Cesarman, E., Lungu, O., Knowles,
D.M., Garber, R., Pellett, P.E., McGeoch, D.J., Chang, Y., 1996. Primary
characterization of a herpesvirus agent associated with Kaposi's sarcomae.
J. Virol. 70 (1), 549–558.
Okuma, K., Nakamura, M., Nakano, S., Niho, Y., Matsuura, Y., 1999. Host
range of human T-cell leukemia virus type I analyzed by a cell fusion-
dependent reporter gene activation assay. Virology 254 (2), 235–244.
Omerovic, J., Lev, L., Longnecker, R., 2005. The amino terminus of Epstein–
Barr virus glycoprotein gH is important for fusion with epithelial and B cells.
J. Virol. 79 (19), 12408–12415.
Pertel, P.E., 2002. Human herpesvirus 8 glycoprotein B (gB), gH, and gL can
mediate cell fusion. J. Virol. 76 (9), 4390–4400.
Pertel, P.E., Spear, P.G., Longnecker, R., 1998. Human herpesvirus-8
glycoprotein B interacts with Epstein–Barr virus (EBV) glycoprotein 110
but fails to complement the infectivity of EBV mutants. Virology 251 (2),
402–413.
Pulford, D., Lowrey, P., Morgan, A.J., 1994. Expression of the Epstein–Barr
virus envelope fusion glycoprotein gp85 gene by a recombinant baculovirus.
J. Gen. Virol. 75 (Pt. 11), 3241–3248.
Pulford, D.J., Lowrey, P., Morgan, A.J., 1995. Co-expression of the Epstein–
Barr virus BXLF2 and BKRF2 genes with a recombinant baculovirus
165J. Omerović, R. Longnecker / Virology 365 (2007) 157–165produces gp85 on the cell surface with antigenic similarity to the native
protein. J. Gen. Virol. 76 (Pt. 12), 3145–3152.
Rivailler, P., Cho, Y.G., Wang, F., 2002a. Complete genomic sequence of an
Epstein–Barr virus-related herpesvirus naturally infecting a new world
primate: a defining point in the evolution of oncogenic lymphocrypto-
viruses. J. Virol. 76 (23), 12055–12068.
Rivailler, P., Jiang, H., Cho, Y.G., Quink, C., Wang, F., 2002b. Complete
nucleotide sequence of the rhesus lymphocryptovirus: genetic validation for
an Epstein–Barr virus animal model. J. Virol. 76 (1), 421–426.
Russo, J.J., Bohenzky, R.A., Chien, M.C., Chen, J., Yan, M., Maddalena, D.,
Parry, J.P., Peruzzi, D., Edelman, I.S., Chang, Y., Moore, P.S., 1996.
Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8).
Proc. Natl. Acad. Sci. U.S.A. 93 (25), 14862–14867.
Silva, A.L., Omerovic, J., Jardetzky, T.S., Longnecker, R., 2004. Mutational
analyses of Epstein–Barr virus glycoprotein 42 reveal functional domains
not involved in receptor binding but required for membrane fusion. J. Virol.
78 (11), 5946–5956.
Spear, P.G., Longnecker, R., 2003. Herpesvirus entry: an update. J. Virol. 77
(19), 10179–10185.
Speck, P., Haan, K.M., Longnecker, R., 2000. Epstein–Barr virus entry into
cells. Virology 277 (1), 1–5.
Strnad, B.C., Schuster, T., Klein, R., Hopkins III, R.F., Witmer, T., Neubauer,
R.H., Rabin, H., 1982. Production and characterization of monoclonalantibodies against the Epstein–Barr virus membrane antigen. J. Virol. 41
(1), 258–264.
Sun, R., Lin, S.F., Gradoville, L., Yuan, Y., Zhu, F., Miller, G., 1998. A viral
gene that activates lytic cycle expression of Kaposi's sarcoma-associated
herpesvirus. Proc. Natl. Acad. Sci. U.S.A. 95 (18), 10866–10871.
Wang, F., 2005. Epstein–Barr virus related lymphocryptoviruses of old and new
world nonhuman primates. In: Robertson, E.S. (Ed.), Epstein–Barr Virus.
Caister Academic Press, Norfolk, England, pp. 691–709.
Wang, X., Kenyon, W.J., Li, Q., Mullberg, J., Hutt-Fletcher, L.M., 1998.
Epstein–Barr virus uses different complexes of glycoproteins gH and gL to
infect B lymphocytes and epithelial cells. J. Virol. 72 (7), 5552–5558.
Wang, F., Rivailler, P., Rao, P., Cho, Y., 2001. Simian homologues of Epstein–
Barr virus. Philos. Trans. R. Soc. Lond., B Biol. Sci. 356 (1408), 489–497.
Wu, L., Hutt-Fletcher, L.M., 2007. Point mutations in EBV gH that abrogate or
differentially affect B cell and epithelial cell fusion. Virology, doi:10.1016/
j.virol.2007.01.025.
Wu, L., Borza, C.M., Hutt-Fletcher, L.M., 2005. Mutations of Epstein–Barr
virus gH that are differentially able to support fusion with B cells or
epithelial cells. J. Virol. 79 (17), 10923–10930.
Yaswen, L.R., Stephens, E.B., Davenport, L.C., Hutt-Fletcher, L.M., 1993.
Epstein–Barr virus glycoprotein gp85 associates with the BKRF2 gene
product and is incompletely processed as a recombinant protein. Virology
195 (2), 387–396.
